Ara
Toplam kayıt 7, listelenen: 1-7
Intravoxel Incoherent Motion Parameters for Assessing the Efficiency of Locoregional Bridging Treatments before Liver Transplantation
(Elsevier Science Inc, 2019)
Objective. To evaluate the diagnostic accuracy of Intravoxel Incoherent Motion (IVIM) parameters for assessment of tumor response after locoregional treatment (LRT) of hepatocellular carcinoma (HCC). Methods. Fifteen ...
Right-lobe Liver Transplant From Donors With Gilbert Syndrome
(BASKENT UNIV, 2012)
Objectives: Donor safety is one of the most important aspects of living-donor liver transplant. The preoperative evaluation of candidates for such transplants essentially starts with serologic and biochemical analyses. ...
Graft-to-Recipient Weight Ratio Threshold Adjusted to the Model for End-Stage Liver Disease Score for Living Donor Liver Transplantation
(WILEY-BLACKWELL, 2016)
The graft-to-recipient weight ratio (GRWR) is an important selection criterion for living donor liver transplantation (LDLT). The generally accepted threshold is known to be 0.8%. We believe that this threshold can be ...
Liver transplantation for homozygote familial hypercholesterolemia: the only curative treatment
(WILEY-BLACKWELL, 2016)
FH is an autosomal dominant genetic disorder characterized by increased TC and LDL level, which leads to xanthomas, atherosclerosis, and cardiac complications even in childhood. The treatment options are diet, medical ...
Living-donor Liver Transplant in 3 Patients With Budd-Chiari Syndrome: Case Report
(BASKENT UNIV, 2012)
Budd-Chiari syndrome is a rare but life-threatening disorder characterized by obstruction of the hepatic venous outflow. Treatment depends on the underlying cause, the location, and extent of the obstruction, and the ...
Normal Primary Graft Function Despite Early Hepatic Artery Thrombosis After Living-Donor Liver Transplant
(Baskent Univ, 2022)
Objectives: Early hepatic artery thrombosis is rare but devastating in living-donor liver transplant recipients. In this study, our aim was to evaluate the results of all patients with early hepatic artery thrombosis at ...
Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis?
(Kare Publ, 2023)
Background and Aim: Combined hepatocellular-cholangiocarcinoma (CHC) requires attention clinically and pathologically after liver transplantation (LT) because of its unique biology, difficulties in diagnosis, and being ...